AMGN Investors Have Opportunity to Lead Amgen Inc. Securities Fraud Lawsuit

LOS ANGELES, March 23, 2023 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Amgen Inc. (“Amgen” or the “Company”) (NASDAQ: AMGN). Class Period: July 29, 2020 –…